Reported 3 days ago
CVS has added four new members to its board, including Glenview Capital’s CEO, as part of a strategy to address performance issues after significant share price declines. This move follows Glenview's substantial $700 million investment in the company, expanding the board to a total of 16 members.
Source: YAHOO